143 related articles for article (PubMed ID: 34182131)
1. Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A
D'Agostino I; Tacconelli S; Bruno A; Contursi A; Mucci L; Hu X; Xie Y; Chakraborty R; Jain K; Sacco A; Zucchelli M; Landolfi R; Dovizio M; Falcone L; Ballerini P; Hwa J; Patrignani P
Pharmacol Res; 2021 Aug; 170():105744. PubMed ID: 34182131
[TBL] [Abstract][Full Text] [Related]
2. Platelet-Specific Deletion of Cyclooxygenase-1 Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice.
Sacco A; Bruno A; Contursi A; Dovizio M; Tacconelli S; Ricciotti E; Guillem-Llobat P; Salvatore T; Di Francesco L; Fullone R; Ballerini P; Arena V; Alberti S; Liu G; Gong Y; Sgambato A; Patrono C; FitzGerald GA; Yu Y; Patrignani P
J Pharmacol Exp Ther; 2019 Sep; 370(3):416-426. PubMed ID: 31248980
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
4. ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.
Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
J Pharm Pharmacol; 1997 Feb; 49(2):187-94. PubMed ID: 9055193
[TBL] [Abstract][Full Text] [Related]
5. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
7. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2.
Lucotti S; Cerutti C; Soyer M; Gil-Bernabé AM; Gomes AL; Allen PD; Smart S; Markelc B; Watson K; Armstrong PC; Mitchell JA; Warner TD; Ridley AJ; Muschel RJ
J Clin Invest; 2019 Mar; 129(5):1845-1862. PubMed ID: 30907747
[TBL] [Abstract][Full Text] [Related]
8. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
[TBL] [Abstract][Full Text] [Related]
9. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.
Pulcinelli FM; Riondino S; Celestini A; Pignatelli P; Trifirò E; Di Renzo L; Violi F
J Thromb Haemost; 2005 Dec; 3(12):2784-9. PubMed ID: 16359516
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
Zaccardi F; Rizzi A; Petrucci G; Ciaffardini F; Tanese L; Pagliaccia F; Cavalca V; Ciminello A; Habib A; Squellerio I; Rizzo P; Tremoli E; Rocca B; Pitocco D; Patrono C
Diabetes; 2016 Feb; 65(2):503-9. PubMed ID: 26470782
[TBL] [Abstract][Full Text] [Related]
12. The antiplatelet agent revacept prevents the increase of systemic thromboxane A
Alberti S; Zhang Q; D'Agostino I; Bruno A; Tacconelli S; Contursi A; Guarnieri S; Dovizio M; Falcone L; Ballerini P; Münch G; Yu Y; Patrignani P
Sci Rep; 2020 Dec; 10(1):21420. PubMed ID: 33293599
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition.
Chłopicki S; Koda M; Chabielska E; Buczko W; Gryglewski RJ
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):715-22. PubMed ID: 11192944
[TBL] [Abstract][Full Text] [Related]
14. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
[TBL] [Abstract][Full Text] [Related]
15. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
Kyrle PA; Eichler HG; Jäger U; Lechner K
Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
[TBL] [Abstract][Full Text] [Related]
17. [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats].
Wei XR; Hu L; Du J
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):89-91. PubMed ID: 10375769
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
Habib A; FitzGerald GA; Maclouf J
J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793
[TBL] [Abstract][Full Text] [Related]
19. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
FitzGerald GA; Lupinetti M; Charman SA; Charman WN
J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060
[TBL] [Abstract][Full Text] [Related]
20. Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.
Patscheke H
Blut; 1990 May; 60(5):261-8. PubMed ID: 2190651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
